Oncology

A promising new study has identified a highly accurate, non-invasive method to diagnose non-small cell lung cancer (NSCLC) using a blood test based on tRNA signatures.

Researchers analyzed over 6,500 treatment episodes between January 2017 and December 2020, with follow-up through June 2024

A new bispecific antibody therapy, AFM28, has shown strong preclinical results in targeting treatment-resistant cells in acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS), according to new research.

A new review highlights the growing role of fibroblast growth factor receptor 2 isoform IIIb (FGFR2b) protein in gastric and gastroesophageal junction (G/GEJ) adenocarcinomas.  

A new AI model, AAnet, reveals that tumours are made up of a continuum of functional cell states. It identifies GLUT3 as a key driver of metastasis.

A new study from Ireland shows that neoadjuvant chemoradiation is safe and effective in older adults with oesophageal cancer, with no survival disadvantage versus younger patients.

Researchers in Germany have developed HANCOCK, a comprehensive dataset of head and neck cancer cases, to support biomarker discovery and precision oncology.

At least 60% of liver cancer diagnoses are linked to modifiable risk factors and could be prevented through global interventions

Higher levels of two cardiac biomarkers at baseline are associated with an increased risk of future cancer…

A new study has found that patients with metastatic non–small cell lung cancer and pre-existing rheumatoid arthritis have similar overall survival to those without RA when treated with immune checkpoint inhibitors…

Scientists have identified a rare and previously overlooked type of circulating tumour cell (CTC) in patients with metastatic breast cancer…

A new study has found that people living with HIV (PWH) in the United States are less likely to receive cancer treatment if they live in areas with lower income or educational attainment.

A new study has found that delaying surgery after a breast cancer diagnosis significantly increases the risk of breast cancer-specific mortality (BCSM), particularly for certain subtypes.

A new study suggests that shorter breastfeeding duration may significantly contribute to higher rates of triple negative breast cancer (TNBC) among Black women compared to their White counterparts.

A new study uncovers how melanomas can arise from minimal genetic changes, shedding light on the early, often elusive steps in skin cancer progression

A new clinical trial offers insight into tackling one of the biggest challenges in soft tissue sarcomas….

Despite alcohol being a leading preventable cause of cancer in the United States, public awareness of its cancer risk remains strikingly low, according to a new study.

A recent study identifies the Gαi3 protein as a key factor in bladder cancer progression. Researchers found that Gαi3 promotes tumour growth and survival by activating the Akt-mTOR pathway.

Researchers have developed an AI system that significantly increases detection of thoracic aortic aneurysms during routine breast MRIs.

Researchers have developed an AI-based multimodal fusion system that combines CT imaging and clinical data to predict survival in patients with unresectable hepatocellular carcinoma.

Research shows patients over 70 experience more complications and a higher death rate following rectal cancer surgery compared to younger patients.

A new study of nearly 129,000 adults has revealed that common midlife comorbidities, such as respiratory and cardiovascular conditions, are associated with an increased risk of cancer and cancer-related death.

A recent multi-centre study reveals taxane-based chemotherapy is linked to markedly better one-year survival in advanced triple-negative breast cancer with genomic instability, compared to platinum-based treatments.

A new study has projected that radiation exposure from computed tomography (CT) scans in the United States will result in approximately 103,000 future cancers.

New research presented at ESMO Breast 2025 reveals that certain gut bacteria and microbial functions are more common in breast cancer patients who later experience recurrence, highlighting the potential of the gut microbiome as a biomarker for relapse risk.

New research presented at ESMO Breast 2025 shows that alcohol consumption raises the risk of developing breast cancer, particularly hormone receptor-positive types, but does not appear to worsen survival or recurrence in those already diagnosed.

New data from ESMO Breast 2025 indicate that inherited DNA repair mutations could affect the effectiveness of CDK4/6 inhibitors in treating advanced breast cancer, with mutation carriers showing lower response rates and shorter survival trends.

New data presented at ESMO Breast 2025 show that short-course radiotherapy offers similar survival outcomes to conventional treatment following surgery and nodal irradiation for breast cancer.

Research shows that regular physical activity can help close the survival gap for stage III colon cancer, with those who exercise achieving survival rates similar to the general population.

Whole genome and transcriptome sequencing (WGTS) outperforms standard gene panels in diagnosing cancer of unknown origin, offering clearer tissue-of-origin insights and broader treatment options, according to new research.

A new study of 18,932 metastatic colorectal cancer patients reveals that microsatellite instability, albumin levels, and antibiotic use significantly impact survival rates when treated with immune checkpoint inhibitors, offering insights for personalised treatment.

A new genomic study has revealed diverse and treatment-influenced mutational patterns in tumours associated with Constitutional Mismatch Repair Deficiency …

A study involving 138 cancer patients found that a personalised lighting intervention, guided by wearable-tracked circadian rhythms, reduced fatigue and improved sleep, anxiety, and physical function.

A study from Hubei Cancer Hospital has found that breast cancer patients undergoing nipple-sparing mastectomy report significantly higher satisfaction with their breast appearance and sexual well-being than those who had skin-sparing mastectomy.

New research highlights the benefits of using Mixed Reality (MR) technology during right hemicolectomy for colon cancer.

New research from the Dutch Melanoma Treatment Registry shows that rechallenging advanced melanoma patients with the immunotherapy combo ipilimumab and nivolumab may offer renewed treatment benefits.

People who develop hypoparathyroidism after thyroid cancer surgery may face a significantly higher risk of several long-term health complications…

A recent study has found that six months of supervised resistance and aerobic exercise significantly improves sexual function in men with prostate cancer, while brief psychosexual education provides no additional benefits.

A new global study analyzing data from 1990 to 2021 uncovers significant regional disparities in female cancer burden. It highlights how risk factors like high BMI, poor diet, and unsafe sex drive the incidence of breast, cervical, and uterine cancers differently across socio-demographic levels.

A study shows that dentists can help identify early signs of childhood leukaemia through clinical and radiographical indicators, offering the potential for quicker diagnosis and improved outcomes.

A study reveals racial disparities in immunotherapy use for triple-negative breast cancer, with Black patients less likely to receive treatment.

A new study reveals a stretchable X-ray detector that converts radiation into visible light, potentially transforming tumour margin detection during surgery.

Aspirin and COX-1 inhibitors may reduce cancer metastasis by enhancing T cell immunity, offering a new treatment approach.

Nivolumab enhances chemotherapy efficacy in high-risk ER+/HER2− breast cancer, offering new treatment potential for early-stage patients.

A recent study has revealed a significant disparity in COVID-19 mortality rates between Non-Hispanic Black and Non-Hispanic White cancer patients….

A study on lung cancer treatment shows that combining photodynamic therapy (PDT) with cisplatin significantly inhibits tumor growth, promoting apoptosis in lung adenocarcinoma cells.

Elevated salivary microvesicles are linked to non-healing oral ulcers and oral cancer, potentially aiding in early diagnosis.

The MITO 40 study, presented at ESGO 2025, highlights promising results for Niraparib as a maintenance treatment in ovarian cancer patients with no residual disease post-surgery.

Rucaparib showed longer progression-free survival, chemotherapy-free interval, and time to first subsequent treatment in advanced ovarian cancer patients, according to updated results from the ATHENA-MONO study.

ESGO 2025 study reveals overestimation of preoperative tumour size in stage IB2 cervical cancer, influencing adjuvant therapy decisions.

At the 2025 ESGO Annual Meeting, researchers unveiled two new diagnostic indices “Vienna Index” and “Top Vienna Index” which combine age with existing ovarian cancer biomarkers, significantly improving detection accuracy.

Study reveals a protein model to predict cardiomyopathy in childhood cancer survivors, enhancing early detection and intervention.

Aspirin was well-tolerated but did not significantly improve disease-free survival in high-risk colorectal cancer patients.

Personalised cancer vaccines show promise in preventing recurrence of high-risk kidney cancer, targeting key driver mutations.

U-Net neural network achieves 98.56% accuracy in brain tumour segmentation, promising advancements in neurological diagnostics and treatment planning.

Study reveals cancer survivors have lower dementia risk, suggesting potential shared biological mechanisms between cancer and neurodegeneration.

Study finds tumour-infiltrating lymphocytes linked to survival in early ERBB2-positive breast cancer, suggesting treatment de-escalation may be possible

New research reveals how aging rewires mammary gland cells, increasing breast cancer risk through epigenetic and immune changes.

Researchers uncover genetic variants that drive cancer risk, revealing new therapeutic targets and refining genetic screening strategies.

A new nomogram predicts microvascular invasion in patients with HCC, aiding preoperative decision-making and improving surgical outcomes.

New model enhances early detection of lymph node metastasis in breast cancer using CEUS images and machine learning.

A new study suggests that cannabidiol (CBD) may help reduce anxiety in women with advanced breast cancer undergoing tumour burden assessments.

AI and ML predict breast cancer recurrence and metastasis, offering new tools for better patient risk assessment and care.

Overexpression of RAD51 genes correlates with poorer prognosis in breast cancer, highlighting its potential as a prognostic biomarker and therapeutic target.

A groundbreaking study investigated repurposing the COVID-19 mRNA vaccine for cancer treatment.

Frequent polyp diagnoses in relatives significantly raise the risk of colorectal cancer, particularly for early-onset cases.

Research shows patients with vitiligo have no increased cancer risk, with reduced risks for melanoma, lung, and bladder cancers.

AI foundation models boost ovarian carcinoma subtyping accuracy, providing clinicians with valuable diagnostic support and efficiency.

A newly updated clinical practice guideline offers healthcare practitioners vital evidence-based recommendations for managing hepatitis B reactivation (HBVr) in individuals at risk.

A recent comprehensive study has offered new insights into the role of human epidermal growth factor 2 (HER2) in male breast cancer…

A recent study has revealed an increased risk of thyroid cancer diagnoses within the first year of starting GLP-1RA therapy.

A French study finds significant increases in digestive cancer risks, including small bowel, pancreatic, and gastric cancers, in celiac patients.

BRCA1/BRCA2 carriers face significantly higher risks of second cancers, including ovarian and pancreatic, after breast cancer.

A study suggests extending colonoscopy rescreening beyond 10 years for low-risk individuals, based on long-term colorectal cancer outcomes.

A new assessment scheme highlights the strengths and limitations of automatic tumour segmentation tools for glioblastoma on MRI.

A recent study has demonstrated the effectiveness of online screening and virtual patient education tools in improving hereditary cancer risk assessments

New compounds targeting PI3Kα show potential in treating triple-negative breast cancer, offering hope for more effective therapies.

Melanomas thicker than 0.8 mm significantly increase the risk of melanoma-related death, a study of over 144,000 patients shows.

A study has revealed that childhood obesity at the time of cancer diagnosis is associated with lower event-free survival and overall survival rates…

A new machine learning-based tool developed by researchers could revolutionise the way doctors diagnose tumours of unknown origin.

A recent study has uncovered a potential connection between environmental metal exposure and an increased risk of digestive tract cancers…

A study examining over 2,300 patients has unveiled promising new genomic biomarkers that could improve prognosis and treatment strategies for pancreatic ductal adenocarcinoma…

New research reveals the dual role of cancer-associated fibroblasts in tumour immunity, offering insights for future cancer therapies.

A recent study has highlighted a significant increase in the use of inpatient palliative care among metastatic testicular cancer patients undergoing critical care therapy between 2008 and 2019…

A recent study examining the effectiveness of a telemedicine-based exercise programme for cancer survivors has shown encouraging results…

A phase 3 clinical trial suggests that stereotactic body radiation therapy prior to systemic treatment may improve survival outcomes for patients with liver cancer.

Colorectal cancer incidence among adults under 50 years is rising in 27 of 50 countries analysed, according to a new global study.

A recent study evaluated the impact of a 3-month home-based exercise and self-management program on physical function in patients after lung resection surgery…

A recent study reveals that tumour upstaging in invasive melanoma occurs in 9.4% of cases and significantly worsens survival outcomes. Read more!

A new cohort study suggests that many men with suspected prostate cancer can safely avoid biopsies after receiving negative MRI results…

Researchers have identified the protein MYO1F as a key regulator of T cell metabolism, with implications for immune responses, cancer, and autoimmune diseases…

A recent study has shed light on improving the prognostication of Merkel cell carcinoma, a rare and aggressive form of skin cancer.

A new systematic review and meta-analysis highlights a significant link between elevated faecal haemoglobin levels and an increased risk of colorectal neoplasia.

This retrospective multicohort analysis, examined 95 patients who received ACT across various clinical trials from 2017 to 2023…

A groundbreaking study has demonstrated that AI-driven liquid biopsies could revolutionise cancer care…

The research aimed to assess the long-term risk of CRC based on colonoscopy screening results and demographic and lifestyle risk factors…

The study followed 18,463 high-risk smokers, who underwent pre-bronchodilator spirometry tests and were tracked over a median period of 6.1 years.

A groundbreaking study has identified a naturally occurring ligand derived from vitamin B6 that can activate immune cells to target tumours…

A recent study has explored the relationship between chronic pain and the risk of death from cerebrovascular disease in cancer patients…

A new study has explored the effectiveness of combining transpulmonary chemoembolisation and microwave ablation for treating non-small cell lung cancer…

A recent study has provided new insights into melanoma incidence and presentations among paediatric and adolescent and young adult patients.

A new study comparing treatment strategies for stage T2N0M0 oesophageal cancer has revealed no significant survival advantage for patients receiving neoadjuvant chemoradiotherapy followed by surgery.

A recent study from the REACT initiative highlights a significant gap in fertility preservation discussions for early-onset cancer patients, with nearly half reporting that they were not informed about fertility options before beginning treatment.

A new study reveals that combining proton beam therapy with boron neutron capture reactions increases its cell-killing effect, with higher boron concentrations yielding stronger therapeutic results…

Restaging MRI is a powerful tool for predicting survival and organ preservation in rectal cancer patients after total neoadjuvant therapy…

A new phase 3 trial (INTERLACE) shows that adding induction chemotherapy to standard chemoradiotherapy improves both progression-free and overall survival in patients with locally advanced cervical cancer.

A new study reveals how the m6A epitranscriptomic modification and MYCN oncogene cooperate to maintain an undifferentiated state in neuroblastoma…

Researchers have developed a novel treatment for non-small cell lung cancer (NSCLC) that uses customised antisense oligonucleotides (ASOs) to selectively target drug-resistant EGFR mutations.

A recent trial found that three cycles of CEV chemotherapy are as effective as six in treating high-risk unilateral retinoblastoma after enucleation.

A recent study uncovers genetic vulnerabilities in glioblastoma stem cells, pinpointing subtype-specific dependencies that drive tumour growth.

A recent study reveals that family members of cancer patients are at greater risk for developing psychological illnesses and cardiovascular diseases. The research highlights the need for better healthcare support for families coping with cancer.

A new clinical trial has found that extended lymphadenectomy does not improve disease-free or overall survival rates compared to standard lymphadenectomy in patients with localized muscle-invasive bladder cancer.

A recent analysis of the National Cancer Database reveals that health insurance plays a crucial role in racial and ethnic disparities in late-stage cancer diagnoses.

Socioeconomic factors influence prostate cancer test participation, with lower income and education linked to reduced uptake in organised screening programs.

Recent analysis from the National Cancer Database (NCDB) reveals a significant uptick in immunotherapy (IO) use for advanced kidney and bladder cancers….

A recent phase 3 trial has demonstrated that stereotactic body radiotherapy (SBRT) is a viable treatment for localised prostate cancer…

A study suggests that selenium, a mineral found in Brazil nuts, may hold the key to preventing the spread of triple negative breast cancer.

A pioneering breast cancer initiative is set to expand to Norfolk and Norwich University Hospital, providing more patients in the East with access to advanced, tailored treatment.

A review found no strong evidence linking radiofrequency electromagnetic fields from mobile phones and other sources to an increased risk of cancer, including brain tumours.

A new South Korean study reveals that patients with Graves’ disease, an autoimmune thyroid disorder, may have an increased risk of developing cancers

A recent study has identified key gene signatures that could help predict the efficacy of immune checkpoint blockade therapy in patients with metastatic melanoma.

A study finds that lower cardiopulmonary fitness is linked to more severe symptoms such as depression, poor sleep quality, and fatigue in newly diagnosed breast cancer patients.

A recent study has examined the potential link between the oral microbiome and the development of head and neck squamous cell cancer

In patients with primary thyroid cancer, there is an increased risk of melanoma and other non-keratinocyte skin cancers after radioactive iodine therapy.

A study has shown that modern radiotherapy techniques, including volumetric modulated arc therapy, significantly improve quality of life in head and neck cancer patients

A Swedish study has shown that total neoadjuvant treatment for locally advanced rectal cancer is effective in routine healthcare settings, offering similar results to the RAPIDO trial

A new study has highlighted shifting trends in head and neck cancers in Scotland, particularly focusing on the past two decades

Researchers have identified that Black women in the United States have significantly higher breast cancer mortality rates than White women

A new study has revealed that proteins found in foods such as meat and milk can help suppress the growth of tumours in the small intestines

A recent study explores serum anti-PD-1 autoantibodies as a potential biomarker for predicting survival outcomes in patients with advanced hepatocellular carcinoma

Researchers from Aston University, Birmingham, UK have developed a potential breakthrough treatment for osteosarcoma, the most common form of bone cancer.

A study on online adaptive radiotherapy reveals reduced treatment margins and lower radiation doses to organs at risk in gastric MALT lymphoma patients

A history of paediatric cancer has been linked to long-term cognitive challenges after treatment, affecting areas such as working memory and processing speed.

A groundbreaking clinical trial testing QH104, an allogeneic B7H3-targeting CAR-γδT cell therapy, has shown promising results for patients with recurrent glioblastoma.

A new study provides the first evidence that breastfeeding is safe for women with BRCA mutations after breast cancer treatment.

Results from the phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study have been presented at ESMO 2024, Barcelona, Spain

The PEACE-3 trial shows that combining Enzalutamide with Radium-223 improves progression-free survival in metastatic castration-resistant prostate cancer.

New clinical trial results, presented at ESMO 2024, show that an investigational mRNA-based vaccine CVGBM is safe and well-tolerated in patient with newly diagnosed MGMT-unmethylated glioblastoma (GBM).

Researchers have made a significant breakthrough in understanding ductal carcinoma in situ, a pre-invasive tumour that can progress to invasive breast cancer.

A new study projects outcomes of breast cancer screening strategies using digital breast tomosynthesis with or without supplemental breast magnetic resonance imaging.

In a new, nonrandomised controlled trial, researchers have found that breast cancer risk was lower in individuals who had undergone bariatric surgery.

A study investigated academic readiness, its predictors, and its relationship with later academic performance in patients treated for CNS tumours during early childhood.

The Breast Cancer Index effectively predicts outcomes and benefits of ovarian function suppression therapy in premenopausal women with HR+ breast cancer.

Research shows annual mammograms lower late-stage breast cancer risk and improve survival compared to less frequent screening

Obesity is linked to improved survival outcomes in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.

A new study found a significant link between chemotherapy-induced disruptions in the gut microbiome and cognitive decline in female patients with breast cancer.

A new study has uncovered a mechanism that drives the evolution of mismatch repair deficient colorectal cancer, a type of cancer known for its high mutation rates.

A recent study has shed light on the concerning link between high sugar consumption and premature aging in adult survivors of childhood cancer.

Recent findings indicate the potential cognitive benefits of hormone-modulating therapy for older women undergoing breast cancer treatment.

A recent study has cast doubt on the long-term mortality benefits of bilateral mastectomy for women with unilateral breast cancer.

Research highlights that aspirin use is associated with a significant reduction in colorectal cancer incidence, particularly among individuals with less healthy lifestyle habits.

New research reveals the impact of diet on the composition and function of our gut microbiome.

New research reveals lower breast cancer risk in women treated for ovarian cancer with BRCA mutations, particularly BRCA2.

Researchers conducted a prospective diagnostic study to explore whether differences in patients’ RAS variants reflected variance in the status of their tumours.

New research explores the link between endometriosis and ovarian cancer risk.

Electronic health record-based prompts have been shown to halve the rate of unnecessary surgery in older patients with early-stage breast cancer.

A new study stresses the importance of a universal screening and opt-out referral strategy that may mitigate disparities in tobacco treatment access and use in cancer care.

A new study highlights significant disparities in next-generation sequencing testing among patients with metastatic prostate cancer and advanced urothelial carcinoma.

A recent study showed that racial and ethnic minority groups have historically been underrepresented in clinical trials.

Researchers have highlighted a link between socioeconomic status and cardiovascular mortality.

Researchers have identified a sharp decrease in cancer-related suicides since 2013.

Acupuncture significantly reduces side effects of endocrine therapy, including hot flashes, in patients with breast cancer.

A recent study found that selective surveillance of individuals at high risk for pancreatic cancer significantly improved clinical outcomes.

Immunosuppression agent exposure is linked to an increased incidence of primary malignant neoplasms in kidney transplant recipients, and this association varies by age and sex.

Researchers have unveiled that Helicobacter pylori treatment may be beneficial for individuals with a high genetic risk to gastric cancer.

Emerging research from the University of South Carolina has revealed racial and ethnic differences in early death after cancer diagnosis.

A new study shows that IMRT offers better long-term outcomes and fewer severe adverse events than 3D-CRT for treating certain lung cancers.

New findings have provided crucial insights into the optimal radiotherapy techniques for treating unresectable locally advanced non–small cell lung cancer.

Synergistic Immune-Mediated Anti-tumour Effect of Dostarlimab and Radiotherapy in the Management of MSI-H/dMMR Endometrial Cancer: A Case Report.

EarlyTect BCD, a new urine-based test, shows high clinical performance in detecting bladder cancer among haematuria patients.

A new trial reveals that combining TACE with sorafenib improves survival for patients with recurrent intermediate-stage hepatocellular carcinoma and positive microvascular invasion.

A recent cohort study has underscored the importance of surveillance in detecting tumours early in paediatric patients with cancer predisposition syndromes.

New research shows that integrating precision genomic testing with targeted therapies improves treatment responses and progression-free survival in pediatric oncology.

An algorithm-based default referrals system has led to a fourfold increase in the use of specialty palliative care within a large community oncology network.

Females with primary ovarian insufficiency, experiencing menopause at ≤40 years, face a heightened risk for breast cancer, and ovarian cancer, according to new research.

Patients with certain cancers treated at practices using more systemic therapy did not have significantly improved survival outcomes compared to those treated at practices using less.

New study suggests that vitamin D supplements may significantly extend the treatment-free survival period for patients with asymptomatic chronic lymphocytic leukaemia

A recent trial has shown that telehealth delivery of early palliative care is as effective as in-person visits for patients with advanced non-small cell lung cancer

A Phase 3 trial reveals that osimertinib significantly extends progression-free survival in patients with unresectable stage III EGFR-mutant non-small cell lung cancer after chemoradiotherapy

Recent research indicates heightened cardiovascular risks when combining androgen receptor signalling inhibitors with androgen deprivation therapy in prostate cancer treatment.

A study reports of a new surgical platform capable of identifying isocitrate dehydrogenase mutations in gliomas in under two minutes.

A recent study found that perioperative FLOT chemotherapy significantly improves survival rates in patients with esophageal adenocarcinoma.

Read results from a trial presented as ASCO 2024, which details the impact that Isa-VRd therapy has in multiple myeloma patients

Read the latest news from ASCO 2024, including on results from the ADRIATIC trial on small-cell lung cancer post-chemoradiotherapy.

New research reveals low-dose CT benefits lower socioeconomic groups, reducing COPD and emphysema mortality

Read the latest research from ASCO 2024, including a trial on treatment that improves event-free survival in Stage III melanoma.

According to a recent study from the Cleveland Clinic, genes may play a significantly larger role in melanoma risk than previously believed

A study reveals significant disparities in cancer staging outcomes for patients treated at the Sidney Kimmel Comprehensive Cancer Center.

New research provides hopeful news for young women treated for breast cancer who wish to have children.

A new retrospective cohort study has revealed concerning findings about the adherence to surveillance guidelines among adult survivors of childhood cancer in Ontario, Canada.

A recent study conducted at the University of Rochester Medical Centre, New York, USA, has shed light on the risk of sudden cardiac death (SCD) among cancer patients undergoing active treatment.

Mortality rates of Melanoma have remained stable despite rising incidence, with reasons for this disparity still unclear.

New findings from a USA telephone survey found that more than one-quarter of cancer survivors reported mobility disability, while close to 10% reported self-care disability

Recent research suggests regular aspirin use may decrease colorectal cancer incidence and mortality by enhancing immunosurveillance and boosting immune response.

A recent cohort study reveals heightened risk of second primary cancers among breast cancer survivors, influenced significantly by age and socioeconomic factors.

Emerging global statistics have revealed that by 2050, there are projected to be 35 million new cases of cancer reported, according to a recent report from the American Cancer Society.

According to new research, one-third of females with breast cancer have reported fertility concerns influencing their treatment decisions, with one-fifth discussing fertility preservation strategies with their physician.

Survivors of childhood cancer with abnormal baseline longitudinal strain and N-terminal pro B-type natriuretic peptide have an increased risk of developing cardiomyopathy, according to recent findings.

Side effects and treatment options in prostate cancer have been illuminated by a recent long-term study. Having followed the cohort for over a decade, the findings from this research bring to light some important points to consider.

Survivors of cancer often experience ongoing pain throughout their lives. According to research, an increasing physical activity may reduce pain intensity for patients with a history of cancer.

This research has the potential to alter the global standard of care for patients with hepatocellular carcinoma, which for more than 20 years has been treatment with TACE alone.

Findings from a new Phase III study show promise for the dual approach of chemotherapy and immunotherapy as a first-line treatment for advanced oesophageal squamous cell carcinoma.

The NRG-GI005 (COBRA) Phase II/III study, the first of its kind, aimed to assess ctDNA clearance as a primary endpoint…

CtDNA may be used to detect molecular residual disease (MRD) in patients, and to monitor the effectiveness of treatment of patients…

Patients with high-grade gastroenteropancreatic neuroendocrine tumours showed…

Females with ovarian cancer have a higher likelihood of hospital mortality if they are Black, American Indian, Asian, and Hispanic, when compared with their White counterparts, according to a recent study.

Patients diagnosed with cryptogenic pyogenic liver abscess had a significantly higher incidence of colorectal cancer up to 3 years after PLA diagnosis compared with control patients, according to recent data.

An updated report from the ACS revealed that individuals with a lower socioeconomic status, populations living in non-metropolitan areas, and Black and American Indian/Alaska Native individuals bear a disproportionately higher burden of cancer-related deaths.

A new study carried out at the University of Gothenburg, Sweden, has found that males who are overweight or obese at age 18 have a higher risk of 17 different cancers later in life.

According to research, the risk of hearing loss is greater in individuals who are survivors of cancer. This is due to age and the effects of previous chemotherapy and radiotherapy. Read more.

Incidence rates for lung cancer in US females aged 35-54 were higher than in males and older females, according to research by Ahmedin Jemal, American Cancer Society, Atlanta, Georgia, USA, and colleagues.

Research from Yangzhou University, China, has identified several barriers to active surveillance, including fear of adverse events, psychological distress, and negative response to diagnosis.

A research team analysed nationally representative data from the 2019 and 2021 National Health Interview Survey, finding that one-third of adults are overdue routine screening for colorectal cancer.

New research shows racial disparities in cancer-related deaths. The risk of cancer-related death is increased for Black and Hispanic patients following diagnosis of a second primary cancer compared with cancer-related death risk for White patients.

Post-menopausal females who drink who drink ≥1 sugar-sweetened drink per day could have a greater risk for liver cancer and chronic liver disease mortality, according to new research.

Combining CDE with OCT significantly improves detection of residual and recurrent superficial basal cell carcinoma…

Breast cancer is the most common type of cancer amongst females, and its risk could be influenced by metabolic abnormalities…

Over the past two decades, age-adjusted mortality rates in kidney cancer have decreased across all genders, races, and ethnicities.

Cardiovascular disease may pose a greater risk to many post-treatment survivors of cancer than cancer recurrence.

Obesity is associated with an increased risk for numerous different cancer types, including gastrointestinal cancers.

Studies reveal that patients with asthma have an elevated risk for several cancer types, (blood, melanoma, ovarian, kidney, and lung cancers)

Solved the mystery of how programmed cell death protein 1 (PD-1) inhibitors work on the immune system’s natural killer (NK) cells…

VITAMIN E could boost immunotherapy responses, according to researchers at The University of Texas MD Anderson Cancer Center…

A new oral, targeted therapeutic has been approved for the treatment of a rare non-small cell lung cancer, offering improved outcomes…

AI systems can identify and grade prostate cancer tissue samples as accurately as pathologists, which could lead to their use as a complementary tool…

Evidence revealed by researchers at Flinders University and UCLA has demonstrated a rise in gastrointestinal cancers in those under 50…

Amivantamab has the potential to address the high unmet need in the treatment of people with EGFR exon 20 insertion mutations in non-small cell lung cancer

Scientists have identified two subtypes of metastatic prostate cancer that responding differently to treatment.

Engaging in 5 hours per week of moderate-intensity exercise could prevent 46,000 cancer cases annually in the USA.

Recent evidence has shown that cancer patients lack seropositivity following a single dose of the Pfizer-BioNTech mRNA COVID-19 vaccine. This urges the need for patients undergoing cancer treatment to be prioritised in the vaccine scheme, as their protection against the virus is delayed, relative to a healthy population.

SURPRISING new evidence has emerged suggesting a strong link between alcohol consumption and an increased risk of developing certain cancers.

PREDICTING which patients with cancer may be at risk of severe side effects from immunotherapy may be improved through the identification of specific risk..

VACCINE therapies for cancers have been a focus for developments in personalised medicine, and a recent Phase I trial has shown promising results…

EXCITING research from a team at the University of Copenhagen, Copenhagen, Denmark, has revealed molecular details of enzymes known as…

HEAD and neck cancer, like any cancer, is truly life-altering,” said Dr Christina Wicker, who is part of a group of researchers from…

PROSTATE cancer is one of the most common cancers worldwide, yet it remains one of the few cancers not to adopt the familiar staging system of Stage I–IV…

DELAYS in treatment, as a result of the coronavirus disease (COVID-19) pandemic, have been experienced by many people with cancer across the world.

INVASION and metastasis of tumour cells poses a significant challenge in cancer treatment; in the face of growing concerns, a team at

COMORBID COVID-19 and cancer is complicated by immunotherapy treatment, which activates an immune system response that may already be overactive

The AACR is dedicated to the rapid dissemination of innovative cancer research that has always been the hallmark of our Annual Meetings…

SIGNIFICANT changes in cancer care are occurring and expected to continue for the duration of the COVID-19 pandemic, a message delivered in a recently…

PATIENT counselling is more important than ever for those with cancer, especially considering the burgeoning number of treatments available…

The AACR Virtual Annual Meeting I will take place April 27-28. This meeting, which will be the first of two virtual meetings, is FREE and will feature an…

A TUMOUR-HIGHLIGHTING agent has been used to aid cardiothoracic surgeons’ visualisation of lung cancer tissue. This is…

ACCOUNTING for 90% of cancer-related deaths, metastasis represents a significant challenge to researchers across the oncological field…

A MULTIDISCIPLINARY team of scientists have successfully demonstrated tumours in mice to be sensitive to a combination approach of immunotherapy…

Astronauts experience physical stress while in space and have a rigorous training programme prior, during, and after their expedition…

Survival rates for those with later-stage cancer are progressively increasing with better treatment and earlier diagnosis…

EATING poultry may be associated with reduced breast cancer risk whereas red meat consumption may increase the likelihood of the disease…

THE KETOGENIC (keto) diet in conjunction with a diabetes drug could augment the effects of chemotherapy, a new study suggests…

THE EFFICACY of immunotherapy vaccines can be impacted by the structure of the vaccine regardless of its composition, a team of researchers from…

TUMOUR mutations could be used to predict patients’ responses to cancer treatment drugs, according to the results of a recent study…

SEXUAL DYSFUNCTION was one of the two major differences in quality of life (QoL) between men treated for advanced prostate cancer…

EMJ Oncology 6.1 is now available, presenting a full review of the European Society for Medical Oncology (ESMO) Congress 2018

Debate has been ongoing for some time in the medical community as to whether screening programmes for breast cancer have any significant impact on the…

Driver mutations that cause cancers to spread are common to all metastases in a single patient, a study from Stanford University, California, USA has…